MedTrace Logo

Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer

NCT06378944 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2024-09-19

No results posted yet for this study

Summary

The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.

Conditions

Interventions

OTHER

Application of green indocyanine colorant

The day of the surgery 1 ml of green indocyanine colorant will be applicated periareolar. After 5 minutes the lymph node will be detected and extracted

DRUG

Technetium99

Application of a periareolar injectionof TEchnetium 99 in order to detect the axillary lymph node

Sponsors & Collaborators

  • Omphis Foundation

    lead OTHER

Principal Investigators

  • Sandra Lopez gordo · 46873584K

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2029-01-01
Completion
2029-01-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06378944 on ClinicalTrials.gov